{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:34:21Z","timestamp":1786988061207,"version":"build-2736575974"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013003","name":"Universit\u00e0 degli Studi di Cagliari","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ejmech.2019.111638","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T11:37:00Z","timestamp":1566473820000},"page":"111638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: Synthesis and biological evaluation"],"prefix":"10.1016","volume":"182","author":[{"given":"Davide","family":"Moi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3342-702X","authenticated-orcid":false,"given":"Alessio","family":"Nocentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Deplano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4437-6096","authenticated-orcid":false,"given":"Gianfranco","family":"Balboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Onnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.111638_bib1","doi-asserted-by":"crossref","first-page":"1141388","DOI":"10.1080\/23312009.2016.1141388","article-title":"Synthesis of focused library of novel aryloxyacids and pyrazoline derivatives: molecular docking studies and antimicrobial investigation","volume":"2","author":"Shubhalaxmi","year":"2016","journal-title":"Cogent. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib2","doi-asserted-by":"crossref","first-page":"102933","DOI":"10.1016\/j.bioorg.2019.102933","article-title":"Synthesis of thymol-based pyrazolines: an effort to perceive novel potent-antimalarials","volume":"88","author":"Raghuvanshi","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejmech.2018.01.082","article-title":"Pyrazole-pyrazoline as promising novel antimalarial agents: a mechanistic study","volume":"149","author":"Kumar","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4155\/fmc-2017-0144","article-title":"Facile synthesis of some pyrazoline-based compounds with promising anti-inflammatory activity","volume":"10","author":"Eid","year":"2018","journal-title":"Future Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2019.111638_bib5","doi-asserted-by":"crossref","first-page":"E484","DOI":"10.3390\/molecules24030484","article-title":"Design, synthesis, docking studies and monoamine oxidase inhibition of a small library of 1-acetyl- and 1-thiocarbamoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazoles","volume":"24","author":"Guglielmi","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2019.111638_bib6","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1039\/C8MD00196K","article-title":"Curcumin-based pyrazoline analogues as selective inhibitors of human monoamine oxidase A","volume":"9","author":"Nath","year":"2018","journal-title":"Med. Chem. Comm."},{"key":"10.1016\/j.ejmech.2019.111638_bib7","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ejmech.2018.01.026","article-title":"Design, synthesis, biological evaluation and docking studies of new 3-(4,5-dihydro-1H-pyrazol\/isoxazol-5-yl)-2-phenyl-1H-indole derivatives as potent antioxidants and 15-lipoxygenase inhibitors","volume":"145","author":"El Bordiny","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib8","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s00044-017-2081-9","article-title":"Design, synthesis, molecular modeling, and ADMET studies of some pyrazoline derivatives as shikimate kinase inhibitors","volume":"27","author":"James","year":"2018","journal-title":"Med. Chem. Res."},{"issue":"9","key":"10.1016\/j.ejmech.2019.111638_bib9","doi-asserted-by":"crossref","first-page":"E2151","DOI":"10.3390\/molecules23092151","article-title":"Design, synthesis, and neuroprotective effects of a series of pyrazolines against 6-hydroxydopamine-induced oxidative stress","volume":"23","author":"\u00d6zdemir","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2019.111638_bib10","first-page":"126","article-title":"N1-benzenesulfonyl-2-pyrazoline hybrids in neurological disorders: syntheses, biological screening, and computational studies","volume":"17","author":"Tripathi","year":"2018","journal-title":"EXCLI J."},{"key":"10.1016\/j.ejmech.2019.111638_bib11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bmc.2018.12.012","article-title":"Synthesis of novel pyrazoline derivatives and the evaluation of death mechanisms involved in their antileukemic activity","volume":"27","author":"Stefanes","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib12","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bioorg.2018.10.038","article-title":"Synthesis and anti-proliferative activity of some new quinoline based 4,5-dihydropyrazoles and their thiazole hybrids as EGFR inhibitors","volume":"83","author":"George","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2019.111638_bib13","doi-asserted-by":"crossref","first-page":"E1956","DOI":"10.3390\/molecules23081956","article-title":"Synthesis of new 1,3,5-triazine-based 2-pyrazolines as potential anticancer agents","volume":"23","author":"Moreno","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2019.111638_bib14","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.ejmech.2018.07.044","article-title":"Novel nicotinoyl pyrazoline derivates bearing N-methyl indole moiety as antitumor agents: design, synthesis and evaluation","volume":"156","author":"Chen","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib15","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ejmech.2018.06.043","article-title":"Design and biological evaluation of novel triaryl pyrazoline derivatives with dioxane moiety for selective BRAFV600E inhibition","volume":"155","author":"Li","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib16","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1007\/s11696-018-0451-5","article-title":"Synthesis, molecular docking, and evaluation of novel bivalent pyrazolinyl-1, 2, 3-triazoles as potential VEGFR TK inhibitors and anti-cancer agents","volume":"72","author":"Abd-Rabou","year":"2018","journal-title":"Chem. Pap."},{"key":"10.1016\/j.ejmech.2019.111638_bib17","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1080\/14756366.2019.1612889","article-title":"Design, synthesis, molecular modelling and biological evaluation of novel substituted pyrimidine derivatives as potential anticancer agents for hepatocellular carcinoma","volume":"34","author":"Ahmed","year":"2019","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib18","first-page":"1","article-title":"4-Bromo-4'-chloro pyrazoline analog of curcumin augmented anticancer activity against human cervical cancer, HeLa cells: in silico-guided analysis, synthesis, and in\u00a0vitro cytotoxicity","volume":"8","author":"Chaudhary","year":"2019","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2019.111638_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.bioorg.2018.01.021","article-title":"New anticancer drug candidates sulfonamides as selective hCA IX or hCA XII inhibitors","volume":"77","author":"Gul","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib20","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bioorg.2018.03.027","article-title":"Anticancer effects of new dibenzenesulfonamides by inducing apoptosis and autophagy pathways and their carbonic anhydrase inhibitory effects on hCA I, hCA II, hCA IX, hCA XII isoenzymes","volume":"78","author":"Gul","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/14756366.2016.1254207","article-title":"Microwave-assisted synthesis and bioevaluation of new sulfonamides","volume":"32","author":"Gul","year":"2017","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/14756366.2016.1217852","article-title":"Synthesis, cytotoxicity and carbonic anhydrase inhibitory activities of new pyrazolines","volume":"31","author":"Kucukoglu","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14756366.2016.1181627","article-title":"Synthesis and carbonic anhydrase inhibitory activities of new thienyl-substituted pyrazoline benzensulfonamides","volume":"31","author":"Mete","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/14756366.2016.1217852","article-title":"Cytotoxicity and carbonic anhydrase inhibitory activities of new pyrazolines","volume":"31","author":"Kucukoglu","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/14756366.2016.1244533","article-title":"carbonic anhydrase I and II inhibition studies of the 1,3,5-trisubstituted-pyrazolines","volume":"32","author":"Gul","year":"2017","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib26","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2019.111638_bib27","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2019.111638_bib28","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2019.111638_bib29","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/13543776.2018.1508453","article-title":"Carbonic anhydrase inhibitors as antitumor\/antimetastatic agents: a patent review (2008-2018)","volume":"28","author":"Nocentini","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2019.111638_bib30","article-title":"Synthesis of novel tris-chalcones and determination of their inhibition profiles against some metabolic enzymes","volume":"43","author":"Burmaoglu","year":"2019","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.ejmech.2019.111638_bib31","doi-asserted-by":"crossref","first-page":"103096","DOI":"10.1016\/j.bioorg.2019.103096","article-title":"The green synthesis and molecular docking of novel N-substituted rhodanines as effective inhibitors for carbonic anhydrase and acetylcholinesterase enzymes","volume":"90","author":"Bayindir","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib32","doi-asserted-by":"crossref","first-page":"103017","DOI":"10.1016\/j.bioorg.2019.103017","article-title":"Synthesis and biological evaluation of bromophenol derivatives with cyclopropyl moiety: ring opening of cyclopropane with monoester","volume":"89","author":"Boztas","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib34","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.bioorg.2019.03.052","article-title":"Design, synthesis, and carbonic anhydrase inhibition activity of benzenesulfonamide-linked novel pyrazoline derivatives","volume":"87","author":"Abdel-Aziz","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib35","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.bioorg.2017.08.012","article-title":"The synthesis of novel sulfamides derived from \u03b2-benzylphenethylamines as acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase enzymes inhibitors","volume":"74","author":"Ak\u0131nc\u0131o\u011flu","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib36","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/j.bmc.2016.04.002","article-title":"Acetylcholinesterase and carbonic anhydrase inhibitory properties of novel urea and sulfamide derivatives incorporating dopaminergic 2-aminotetralin scaffolds","volume":"24","author":"\u00d6zgeri\u015f","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib37","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1016\/j.bmc.2015.04.019","article-title":"Discovery of potent carbonic anhydrase and acetylcholine esterase inhibitors: novel sulfamoylcarbamates and sulfamides derived from acetophenones","volume":"23","author":"Ak\u0131nc\u0131o\u011flu","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib38","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.bioorg.2018.12.028","article-title":"Synthesis and bioactivities of pyrazoline benzensulfonamides as carbonic anhydrase and acetylcholinesterase inhibitors with low cytotoxicity","volume":"84","author":"Ozmen Ozgun","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib39","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/cbdd.13149","article-title":"Synthesis, molecular modeling, and biological evaluation of 4-[5-aryl-3-(thiophen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl]benzenesulfonamides toward acetylcholinesterase, carbonic anhydrase I and II enzymes","volume":"91","author":"Yamali","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2019.111638_bib40","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/med.20021","article-title":"Sulafamates and their therapeutic potential","volume":"25","author":"Winum","year":"2005","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2019.111638_bib41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bmcl.2003.09.064","article-title":"Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with EMATE, a dual inhibitor of carbonic anhydrases and steroid sulfatase","volume":"14","author":"Abbate","year":"2004","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111638_bib42","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejmech.2014.07.014","article-title":"Cyclic tertiary sulfamates: selective inhibition of the tumor-associated carbonic anhydrases IX and XII by N- and O-substituted acesulfame derivatives","volume":"84","author":"De Monte","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib43","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1016\/j.bmc.2015.07.024","article-title":"Synthesis and carbonic anhydrase I, II, IX and XII inhibitory activity of sulfamates incorporating piperazinyl-ureido moieties","volume":"23","author":"Congiu","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib44","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.bioorg.2018.02.021","article-title":"Synthesis and biological evaluation of novel pyrazoline-based aromatic sulfamates with potent carbonic anhydrase isoforms II, IV and IX inhibitory efficacy","volume":"77","author":"Nocentini","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib45","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1021\/jm00169a021","article-title":"Chalcones: a new class of antimitotic agents","volume":"33","author":"Edwards","year":"1990","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib46","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0223-5234(02)01387-9","article-title":"Synthesis and inhibitory activity of dimethylamino-chalcone derivatives on the induction of nitric oxide synthase","volume":"37","author":"Rojas","year":"2002","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib47","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1016\/j.bmcl.2016.11.017","article-title":"Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides","volume":"26","author":"Arslan","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111638_bib48","doi-asserted-by":"crossref","first-page":"6238","DOI":"10.1016\/j.bmc.2010.07.037","article-title":"Synthesis and in\u00a0vitro antitumor activity of new 4,5-dihydropyrazole derivatives","volume":"18","author":"Congiu","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib49","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.bmcl.2005.02.055","article-title":"Kinesin spindle protein (KSP) inhibitors. Part 1: the discovery of 3,5-diaryl-4,5-dihydropyrazoles as potent and selective inhibitors of the mitotic kinesin KSP","volume":"15","author":"Cox","year":"2005","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111638_bib50","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase","volume":"246","author":"Khalifah","year":"1971","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib51","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/cmdc.201700690","article-title":"Design, synthesis, and biological evaluation of pyrazoline-based hydroxamic acid derivatives as Aminopeptidase N (APN) inhibitors","volume":"13","author":"Cao","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2019.111638_bib52","first-page":"10767","article-title":"Design, synthesis, and fungicidal activities of new strobilurin derivatives","volume":"56","author":"Wei","year":"2008","journal-title":"J.\u00a0Agr. Food Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib53","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.ejmech.2017.11.081","article-title":"O2-(2,4-dinitrophenyl)diazeniumdiolates derivatives: design, synthesis, cytotoxic evaluation and reversing MDR in MCF-7\/ADR cells","volume":"143","author":"Li","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib54","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3998\/ark.5550190.0006.a17","article-title":"Synthesis of hydroxylated 3,5-diaryl-2-pyrazolines by the reaction of hydroxychalcones with hydrazines","volume":"10","author":"L\u00e9vai","year":"2005","journal-title":"ARKIVOC"},{"key":"10.1016\/j.ejmech.2019.111638_bib55","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s10600-012-0159-7","article-title":"Synthesis and antitumor activity of 1-acetyl-3-(4-phenyl)-4,5-dihydro-2-pyrazoline-5-phenylursolate and 4-chalcone ursolate derivatives","volume":"48","author":"Bai","year":"2012","journal-title":"Chem. Nat. Comp."},{"key":"10.1016\/j.ejmech.2019.111638_bib56","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/j.bmc.2017.02.037","article-title":"Synthesis of bulky-tailed sulfonamides incorporating pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-1(5H)-yl) moieties and evaluation of their carbonic anhydrases I, II, IV and IX inhibitory effects","volume":"25","author":"Fares","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib57","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1016\/j.bmc.2017.03.026","article-title":"Inhibition of Malassezia globosa carbonic anhydrase with phenols","volume":"25","author":"Entezari Heravi","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib58","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1021\/acs.jmedchem.5b01343","article-title":"Efficient expression and crystallization system of cancer-associated carbonic anhydrase isoform IX","volume":"58","author":"Leitans","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib59","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1021\/acs.jmedchem.8b00625","article-title":"Discovery of \u03b2-adrenergic receptors blocker-carbonic anhydrase inhibitor hybrids for multitargeted antiglaucoma therapy","volume":"61","author":"Nocentini","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib60","doi-asserted-by":"crossref","first-page":"10860","DOI":"10.1021\/acs.jmedchem.8b01504","article-title":"4-Hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms IX and XII showing hypoxia-enhanced antiproliferative profiles","volume":"61","author":"Nocentini","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111638_bib61","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/chem.201805039","article-title":"Phosphorus versus sulfur: discovery of benzenephosphonamidates as versatile sulfonamide-mimic chemotypes acting as carbonic anhydrase inhibitors","volume":"25","author":"Nocentini","year":"2019","journal-title":"Chemistry"},{"key":"10.1016\/j.ejmech.2019.111638_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2018.04.016","article-title":"Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: selective inhibitors for the tumor-associated hCA IX isoform","volume":"152","author":"Ibrahim","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2019.111638_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003571","article-title":"rDock: a fast, versatile and open source program for docking ligands to proteins and nucleic acids","volume":"10","author":"Ruiz-Carmona","year":"2014","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ejmech.2019.111638_bib64","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1021\/acs.jctc.7b00480","article-title":"High-throughput automated preparation and simulation of membrane proteins with HTMD","volume":"13","author":"Doerr","year":"2017","journal-title":"J.\u00a0Chem. Theory Comput."},{"key":"10.1016\/j.ejmech.2019.111638_bib65","author":"RDKit"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341930772X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341930772X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:01:35Z","timestamp":1759327295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352341930772X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":65,"alternative-id":["S022352341930772X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111638","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: Synthesis and biological evaluation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111638","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111638"}}